EUVIMEDEUVIMED entdecken
Kohortenstudie

Risk Factors for Lower Adherence to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer: A Nationwide Retrospective Cohort Study in Japan

Yasutaka Ihara, Shoichiro Yamamoto, Megumi Mizutani, Shinji Akiyama, Naoto Okada, Yuki Shimomura

Oncology · 2025

DOI: 10.1159/000548812 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Oncology, 2025. Verfasst von Yasutaka Ihara und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Promotion Unit, Clinical Therapeutic Trial Center, Ehime University Hospital, Ehime, Japan, ihara.yasutaka.gr@ehime-u.ac.jp. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Protein Kinase Inhibitors, Lung Neoplasms, Drug Monitoring. Die Arbeit nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The prognosis of patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer has improved with the introduction of oral EGFR-tyrosine kinase inhibitor (TKI). Lower adherence to oral anticancer medications is reportedly associated with a poor prognosis. It is important to understand the causes of lower adherence to oral anticancer medications. We aimed to assess the potential risk factors associated with low adherence to EGFR-TKIs in a real-world clinical setting using administrative claims data in Japan.

Methods

We identified 10,809 outpatients routinely prescribed EGFR-TKIs between December 2015 and January 2023. Adherence to EGFR-TKIs was assessed based on the medication possession ratio (MPR) during the 12-month follow-up period from the date of first outpatient EGFR-TKI prescription. Multivariable linear regression analysis was performed to identify the potential risk factors associated with lower adherence.

Results

The mean (standard deviation) MPR was 94.1% (14.0). Lower adherence was associated with increasing age (per 10-year increase), female sex, dysphagia, and a higher number of concomitant oral medications (per doubling of the count).

Conclusion

Adherence to EGFR-TKIs was generally high, but the findings support tailored adherence strategies, especially for older patients and for those with a higher number of concomitant oral medications, including medication review to reduce pill burden and proactive support for swallowing difficulties.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungProtein Kinase InhibitorsLung NeoplasmsDrug MonitoringHumansFemaleJapanErbB ReceptorsRetrospective StudiesAgedRisk FactorsMaleMiddle AgedAged, 80 and over

Stichwörter der Autor:innen

AdherenceEpidermal growth factor receptor-tyrosine kinase inhibitorsNon-small cell lung cancerReal-world data

Substanzen

Protein Kinase InhibitorsErbB ReceptorsEGFR protein, human

Autor:innen und Institutionen

  • Clinical Research Promotion Unit, Clinical Therapeutic Trial Center, Ehime University Hospital, Ehime, Japan, ihara.yasutaka.gr@ehime-u.ac.jp.
  • Center for Data Science, Ehime University, Ehime, Japan, ihara.yasutaka.gr@ehime-u.ac.jp.
  • Integrated Medical and Agricultural School of Public Health, Ehime University, Ehime, Japan, ihara.yasutaka.gr@ehime-u.ac.jp.
  • Department of Cardiology, Pulmonology, Hypertension and Nephrology, Graduate School of Medicine, Ehime University, Ehime, Japan.
  • Department of Clinical Oncology, Ehime University Graduate School of Medicine, Ehime University, Ehime, Japan.
  • Department of Respiratory Medicine, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.

Zitieren

APA

Ihara, Y., Yamamoto, S., Mizutani, M., Akiyama, S., Okada, N., & Shimomura, Y. (2025). Risk Factors for Lower Adherence to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer: A Nationwide Retrospective Cohort Study in Japan. Oncology. https://doi.org/10.1159/000548812

Vancouver

Ihara Y, Yamamoto S, Mizutani M, Akiyama S, Okada N, Shimomura Y. Risk Factors for Lower Adherence to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer: A Nationwide Retrospective Cohort Study in Japan. Oncology. 2025. doi:10.1159/000548812

BibTeX
@article{Ihara2025,
  author = {Ihara, Yasutaka and Yamamoto, Shoichiro and Mizutani, Megumi and Akiyama, Shinji and Okada, Naoto and Shimomura, Yuki},
  title = {Risk Factors for Lower Adherence to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer: A Nationwide Retrospective Cohort Study in Japan},
  journal = {Oncology},
  year = {2025},
  doi = {10.1159/000548812}
}
Kostenlos starten →